Incyte Corporation(NASDAQ:INCY) 
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; PEMAZYRE, a fibrobla...
Website: http://www.incyte.com
Founded: 2002
Full Time Employees: 1,456
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 62.65
H 63.57
L 60.41
C 60.58
V 3,668,151
10EMA 60.58
20EMA 60.58
60EMA 60.58
120EMA 60.58
250EMA 60.58